Stacey Kowal
Overview
Explore the profile of Stacey Kowal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mickle A, Ciaccio C, Seetasith A, Johnston K, Dunne J, Kowal S, et al.
Curr Med Res Opin
. 2025 Jan;
41(2):269-279.
PMID: 39882592
Objective: To quantify treatment preferences for food allergy management options (oral immunotherapy, biologic therapy, and allergen avoidance), overall and by sociodemographic strata. Methods: A US general population (≥13 years) discrete...
2.
Griffiths M, Cookson R, Avancena A, Espinoza M, Jacobsen C, Sussell J, et al.
Value Health
. 2025 Jan;
28(1):16-24.
PMID: 39779065
Objectives: Disparities in health and healthcare between more and less socially advantaged groups are pervasive, multidimensional, and far-reaching. The material and social conditions in which people are born, grow, work,...
3.
Synnott P, Majda T, Lin P, Ollendorf D, Zhu Y, Kowal S
JAMA Netw Open
. 2024 Oct;
7(10):e2442353.
PMID: 39480421
Importance: The arrival of new medications for Alzheimer disease (AD) has prompted efforts to measure their value using conventional cost-effectiveness analyses; however, these analyses focus on how much health improvement...
4.
Kowal S, Rosettie K
Pharmacoeconomics
. 2024 Oct;
43(1):67-82.
PMID: 39388034
Objectives: We conducted a distributional cost-effectiveness analysis to evaluate how coverage of tocilizumab for inpatients with COVID-19 from 2021 to present impacted health equity in the USA. Methods: A published,...
5.
Ciaccio C, Dunne J, Bever A, Johnston K, Kowal S, Seetasith A, et al.
Patient Prefer Adherence
. 2024 Sep;
18:1949-1960.
PMID: 39318369
Purpose: The quality of life (QoL) impact of food allergies extends beyond severe allergic reactions, as food avoidance can permeate the daily lives of individuals with food allergies and their...
6.
Levine A, Enright D, Clifford K, Kowal S, Chambers J
Appl Health Econ Health Policy
. 2024 Sep;
22(6):827-832.
PMID: 39225746
Objective: The aim of this study was to examine the association between characteristics of novel drugs and incremental health gains relative to standard of care, in terms of quality-adjusted life-years...
7.
Campbell D, Pandey R, Bloudek L, Carlson J, Wallick C, Veenstra D, et al.
J Manag Care Spec Pharm
. 2024 Aug;
30(9):1013-1024.
PMID: 39213143
Background: The impacts of disease and treatment on a patient's family members and informal caregivers are known as "family spillover effects." Although many formal value frameworks call for the consideration...
8.
Li M, Elsisi Z, Wong W, Kowal S, Veenstra D, Garrison Jr L
Value Health
. 2024 Aug;
27(12):1671-1678.
PMID: 39127254
Objectives: Survival benefit from anticancer treatments, even if modest, improves a patient's chances of accessing future innovations, thereby creating real option value. There is no empirical evidence on the impact...
9.
Wong W, Kowal S, To T, Patel A, Veenstra D, Garrison L, et al.
Future Oncol
. 2024 Jan;
20(16):1099-1110.
PMID: 38258557
We investigated the effect of shortening time between innovations with the accelerated approval (AA) pathway on patient outcomes for three solid tumors. This real-world analysis evaluated patients receiving sequential AA...
10.
Riley A, Mule C, Lerner D, Belter L, OToole C, Kowal S, et al.
Cost Eff Resour Alloc
. 2023 Aug;
21(1):55.
PMID: 37612702
Background: U.S. cost-effectiveness recommendations suggest that analyses should include all costs and effects relevant to the decision problem [1]. However, in many diseases, including spinal muscular atrophy (SMA), few studies...